Network pharmacology combined with molecular docking revealed the potential targets of Coridius chinensis in prostate cancer treatment

doi:10.12998/wjcc.v12.i27.6094

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 27

This Article

(142)

(169)

(0)

(8)

(3787)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Sep 26, 2024; 12(27): 6094-6104
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6094

Full Size Figure Download Figure

Figure 2 The component–target network of Coridius chinensis. The network consists of 89 components and 284 corresponding targets. The yellow triangle represents Coridius chinensis (Cc), the blue circles represent the components of Cc, and the purple quadrangles represent potential targets.

Citation: Zhang M, Ma J, Zeng FY, Hou XH. Network pharmacology combined with molecular docking revealed the potential targets of Coridius chinensis in prostate cancer treatment. World J Clin Cases 2024; 12(27): 6094-6104
URL: https://www.wjgnet.com/2307-8960/full/v12/i27/6094.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i27.6094

Zhang M, Ma J, Zeng FY, Hou XH. Network pharmacology combined with molecular docking revealed the potential targets of Coridius chinensis in prostate cancer treatment. World J Clin Cases 2024; 12(27): 6094-6104 [PMID: 39328854 DOI: 10.12998/wjcc.v12.i27.6094]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.